Clinical Trials Directory

Trials / Completed

CompletedNCT03699462

The Effect of Balanced Crystalloid Versus 5% Albumin on Endothelial Glycocalyx Degradation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
106 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

It is being revealed that the more severe the damage of the endothelial glycocalyx (EG) layer, the more likely it is that the prognosis of the patients is poor. For that reason, research is being actively conducted on methods for reducing damage and promoting recovery of the EG layer.The natural regeneration process of the EG layer is up to 7 days. Considering the fact that it is quiet slow, reducing the damage of EG layer is considered to be very important for improving the prognosis of patients undergoing surgery, but there is no clinically proven method. One of the ways receiving attention to reduce damage of EG layer is to stabilize the layer through fluid therapy with albumin. The purpose of this study is to compare the protective effect of the EG layer according to the type of fluid (balanced crystalloid solution vs. 5% albumin) during surgery in patients undergoing off-pump coronary artery bypass surgery.

Conditions

Interventions

TypeNameDescription
DRUGPlasma solution-A injectionThe group receiving balanced crystalloid solution (Plasma solution-A injection, CJ Pharma, South Korea) during surgery
DRUG5% AlbuminThe group receiving 5% albumin (Albumin 5% inj, Green cross, South Korea) during surgery

Timeline

Start date
2018-11-13
Primary completion
2020-10-17
Completion
2020-10-17
First posted
2018-10-09
Last updated
2020-11-02

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03699462. Inclusion in this directory is not an endorsement.